ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes
Odds of Cardiovascular Events Up for RSV Hospitalization Versus COVID-19 Hospitalization
Odds of any acute cardiovascular event increased when compared with COVID-19 hospitalizations in boosted and unboosted individuals
RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women
ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances Survival in Lung Cancer
Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy
FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and older
FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
Approval is for adult patients with COPD with eosinophilic inflammation
Severe Exacerbations Down With As-Needed Albuterol-Budesonide for Mild Asthma
Severe exacerbation occurred in fewer patients receiving albuterol-budesonide versus those receiving albuterol only
Intravenous Tenecteplase Beneficial Before Endovascular Thrombectomy
Higher functional independence seen at 90 days for patients with acute ischemic stroke due to large vessel occlusion who present within 4.5 hours
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
Patients with HSV-1 who used antiherpetics were less likely to develop Alzheimer disease than those who did not
